Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03258567 |
|---|---|
| Brief Title: | Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas |
| First Submitted : | August 22, 2017 |
| First Submitted that Met QC Criteria : | August 22, 2017 |
| First Posted : | August 23, 2017 |
| Last Update Submitted that Met QC Criteria : | December 9, 2020 |
| Last Update Posted : | December 10, 2020 |